Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Michael Walter

Michael Walter
Managing Editor


Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

LATEST ARTICLES BY THIS AUTHOR

Medtronic and Abbott make progress on interoperable diabetes tech—is FDA clearance next?
Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns
Atrial Fibrillation Centers of Excellence: The best path forward for high-quality care and better outcomes
Underweight TAVR patients face higher mortality risk—obesity makes no significant impact
Cardiologists make history, perform world’s first ventricular ablation guided by real-time MRI
Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients
FDA sees potential in new pacemaker-guided hypertension therapy
Perfuze celebrates a ‘major milestone’ for new-look stroke catheter
Myval TAVR valve non-inferior to Sapien 3 after 1 year—pacemaker implants the biggest difference
AI-powered risk model evaluates long-term risk of coronary artery disease

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …70
    • Page 71
    • Page 72
    • Page 73
    • Current page 74
    • Page 75
    • Page 76
    • Page 77
    • Page 78 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme